Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine R Tuttle

Showing results (31-40 of 355) with videos related to

Pageof 36
Sort By:
The New England Journal of Medicine|November 12, 2013
New therapies for diabetic kidney diseaseJonathan Himmelfarb, Katherine R Tuttle
Clinical Journal of the American Society of Nephrology : CJASN|March 12, 2025
Extending Kidney Protective Therapy to Type 1 Diabetes: The Time is NowJoshua J Neumiller, Katherine R Tuttle
Nephrology News & Issues|July 25, 2006
NKF releases new KDOQI guidelines for diabetes and CKDRobert G Nelson, Katherine R Tuttle
Diabetes|July 21, 2021
Glycemic Variability and KIM-1-Induced Inflammation in the Diabetic KidneyKatherine R Tuttle, Radica Z Alicic
Seminars in Nephrology|January 22, 2005
Clinical evidence for the influence of uric acid on hypertension, cardiovascular disease, and kidney disease: a statistical modeling perspectiveRobert A Short, Katherine R Tuttle
Cardiology Clinics|July 13, 2010
Influence of glycemic control on the development of diabetic cardiovascular and kidney diseaseSandeep A Saha, Katherine R Tuttle
Seminars in Dialysis|April 9, 2010
Management of the diabetic patient with advanced chronic kidney diseaseRadica Z Alicic, Katherine R Tuttle
Trends in Cardiovascular Medicine|February 6, 2017
Dietary strategies for cardiovascular healthBrad P Dieter, Katherine R Tuttle
Clinical Journal of the American Society of Nephrology : CJASN|March 10, 2020
Liraglutide for the Treatment of Type 2 Diabetes and Safety in Diabetic Kidney Disease: Liraglutide and Diabetic Kidney DiseaseDavid Z Cherney, Katherine R Tuttle
Kidney360|June 20, 2022
Perspective on Nonsteroidal Mineralocorticoid Receptor Antagonism in Diabetic Kidney DiseaseJasleen K Ghuman, Katherine R Tuttle
Pageof 36

Showing results (31-40 of 355) with videos related to

Sort By:
Pageof 36
The New England Journal of Medicine|November 12, 2013
New therapies for diabetic kidney diseaseJonathan Himmelfarb, Katherine R Tuttle
Clinical Journal of the American Society of Nephrology : CJASN|March 12, 2025
Extending Kidney Protective Therapy to Type 1 Diabetes: The Time is NowJoshua J Neumiller, Katherine R Tuttle
Nephrology News & Issues|July 25, 2006
NKF releases new KDOQI guidelines for diabetes and CKDRobert G Nelson, Katherine R Tuttle
Diabetes|July 21, 2021
Glycemic Variability and KIM-1-Induced Inflammation in the Diabetic KidneyKatherine R Tuttle, Radica Z Alicic
Seminars in Nephrology|January 22, 2005
Clinical evidence for the influence of uric acid on hypertension, cardiovascular disease, and kidney disease: a statistical modeling perspectiveRobert A Short, Katherine R Tuttle
Cardiology Clinics|July 13, 2010
Influence of glycemic control on the development of diabetic cardiovascular and kidney diseaseSandeep A Saha, Katherine R Tuttle
Seminars in Dialysis|April 9, 2010
Management of the diabetic patient with advanced chronic kidney diseaseRadica Z Alicic, Katherine R Tuttle
Trends in Cardiovascular Medicine|February 6, 2017
Dietary strategies for cardiovascular healthBrad P Dieter, Katherine R Tuttle
Clinical Journal of the American Society of Nephrology : CJASN|March 10, 2020
Liraglutide for the Treatment of Type 2 Diabetes and Safety in Diabetic Kidney Disease: Liraglutide and Diabetic Kidney DiseaseDavid Z Cherney, Katherine R Tuttle
Kidney360|June 20, 2022
Perspective on Nonsteroidal Mineralocorticoid Receptor Antagonism in Diabetic Kidney DiseaseJasleen K Ghuman, Katherine R Tuttle
Pageof 36